We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effect of oral nitrates on pulse pressure and arterial elasticity in patients aged over 65 years with refractory isolated systolic hypertension: study protocol for a randomized controlled trial.
- Authors
Abad-Pérez, Daniel; Novella-Arribas, Blanca; Rodríguez-Salvanés, Francisco J.; Sánchez-Gómez, Luis M.; García-Polo, Iluminada; Verge-González, Carmen; Suárez-Fernández, Carmen
- Abstract
Background Isolated systolic hypertension is a highly prevalent disease among the elderly. The little available evidence on the efficacy of nitrates for treating the disease is based on small experimental studies. Methods/design We performed a multicenter, randomized, double-blind, phase III, placebo-controlled trial in 154 patients aged over 65 years with refractory isolated systolic hypertension. Patients were randomized to placebo or 40 mg/day of extended-release isosorbide mononitrate added to standard therapy and titrated to 60 mg/day at week 6 if blood pressure exceeded 140/90 mmHg. The primary objective was to assess the effect on clinical pulse pressure of extended-release isosorbide mononitrate added to standard therapy in patients aged over 65 years with refractory isolated systolic hypertension after 3 months of treatment. The secondary objectives were as follows: to quantify the effect of adding study drug on central blood pressure and vascular compliance using the augmentation index and pulse wave velocity; to evaluate the safety profile by recording adverse effects (frequency, type, severity) and the percentage of patients who had to withdraw from the trial because of adverse events; to quantify the percentage of patients who reach a clinical systolic blood pressure <140 mmHg or <130 mmHg measured by ambulatory blood pressure monitoring; and to quantify the change in pulse pressure measured by ambulatory blood pressure monitoring. Discussion Few clinical trials have been carried out to test the effect of oral nitrates on isolated systolic hypertension, even though these agents seem to be effective. Treatment with extended-release isosorbide mononitrate could improve control of systolic blood pressure without severe side effects, thus helping to reduce the morbidity and mortality of the disease. Trial registration EUDRACT Number: 2012-002988-10
- Subjects
NITRATES; HYPERTENSION; ISOSORBIDE dinitrate (Drug); RANDOMIZED controlled trials; AMBULATORY blood pressure monitoring; CLINICAL trials
- Publication
Trials, 2013, Vol 14, Issue 1, p1
- ISSN
1745-6215
- Publication type
Article
- DOI
10.1186/1745-6215-14-388